Onconova Therapeutics (ONTX)
NASDAQ:ONTX
Holding ONTX?
Track your performance easily

Onconova Therapeutics (ONTX) Income Statement

1,793 Followers

Onconova Therapeutics Income Statement

Last quarter (Q3 2023), Onconova Therapeutics's total revenue was $57.00K, a decrease of 0.00% from the same quarter last year. In Q3, Onconova Therapeutics's net income was $-4.74M. See Onconova Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 226.00K$ 226.00K$ 226.00K$ 231.00K$ 2.18M$ 1.23M
Cost of Revenue
------
Gross Profit
$ 226.00K$ 226.00K$ 226.00K---
Operating Expense
$ 10.22M$ -19.85M$ -16.72M$ 25.22M$ 23.88M$ 24.51M
Operating Income
$ -21.57M$ -19.63M$ -16.50M$ -24.99M$ -21.70M$ -23.28M
Net Non Operating Interest Income Expense
$ 651.00K$ 651.00K----
Other Income Expense
$ -1.39M$ -663.00K$ -333.00K$ -160.00K$ 206.00K$ 2.75M
Pretax Income
$ -20.18M$ -18.96M$ -16.16M$ -25.15M$ -21.49M$ -20.53M
Tax Provision
---$ 4.00K$ 10.00K$ -124.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -20.18M$ -18.96M$ -16.16M$ -25.16M$ -21.50M$ -20.57M
Basic EPS
$ -0.97$ -0.91$ -0.96$ -2.10$ -22.35$ -74.85
Diluted EPS
$ -0.97$ -0.91$ -0.96$ -2.10$ -22.35$ -74.85
Basic Average Shares
$ 83.85M$ 20.91M$ 16.83M$ 11.60M$ 958.97K$ 274.94K
Diluted Average Shares
$ 83.85M$ 20.91M$ 16.83M$ 11.60M$ 958.97K$ 274.94K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 10.22M$ -19.85M$ -16.72M$ 25.22M$ 23.88M$ 24.51M
Net Income From Continuing And Discontinued Operation
$ -20.18M$ -18.96M$ -16.16M$ -25.16M$ -21.50M$ -20.57M
Normalized Income
$ -7.10M--$ -25.01M$ -21.55M$ -22.16M
Interest Expense
------
EBIT
$ -20.84M$ -18.96M$ -16.16M$ -24.99M$ -21.70M$ -23.28M
EBITDA
$ -20.82M$ -18.95M$ -16.15M$ -24.98M$ -21.68M$ -23.23M
Currency in USD

Onconova Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis